Avacta Group Plc (AVCT) - Product Pipeline Analysis, 2017 Update

1 of 5

FEATURED COMPANIES

  • Deltex Medical Group Plc
  • GlySure Ltd
  • Haemair Ltd
  • Lidco Group Plc
  • Smith & Nephew Plc
  • MORE
Summary

Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics which are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It operates in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Avacta Group Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Deltex Medical Group Plc
  • GlySure Ltd
  • Haemair Ltd
  • Lidco Group Plc
  • Smith & Nephew Plc
  • MORE
Avacta Group Plc Company Overview
Avacta Group Plc Company Snapshot
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Avacta Group Plc - Pipeline Analysis Overview
Avacta Group Plc - Key Facts
Avacta Group Plc - Major Products and Services
Avacta Group Plc Pipeline Products by Development Stage
Avacta Group Plc Pipeline Products Overview
Depression Test
Depression Test Product Overview
Diagnostic Assay - Alzheimer's Disease
Diagnostic Assay - Alzheimer's Disease Product Overview
Diagnostic Test - ADHD
Diagnostic Test - ADHD Product Overview
Diagnostic Test - Bipolar Disorder
Diagnostic Test - Bipolar Disorder Product Overview
Point-Of-Care Diagnostic Test - Zika Virus
Point-Of-Care Diagnostic Test - Zika Virus Product Overview
Portable Pathogen Detection System
Portable Pathogen Detection System Product Overview
Rapid Diagnostic Test - Bacterial Strains
Rapid Diagnostic Test - Bacterial Strains Product Overview
Rapid Diagnostic Test - Infectious Diseases
Rapid Diagnostic Test - Infectious Diseases Product Overview
Schizophrenia Response Test
Schizophrenia Response Test Product Overview
Schizophrenia Side Effects Test
Schizophrenia Side Effects Test Product Overview
Avacta Group Plc - Key Competitors
Avacta Group Plc - Key Employees
Avacta Group Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Avacta Group Plc, Recent Developments
Nov 15, 2017: Covance to Present Affimer Data at European Conference
Oct 02, 2017: Avacta Establishes US Business Development Team
Aug 07, 2017: Avacta Group: Trading Update and Notice of Results
May 10, 2017: Avacta Group: Key Affimer patent to be granted in China
May 10, 2017: Avacta: Key Affimer patent to be granted in China
Apr 03, 2017: Excellent results for Affimer technology in Industry-standard immunogenicity study using human samples
Apr 03, 2017: Avacta Group: Interim results for the period ended 31 January 2017
Jan 20, 2017: AGM business update and notice of results
Nov 07, 2016: Avacta Group: World-Leading Cancer Stem cell Expert Joins Avacta Scientific Advisory Board
Oct 17, 2016: Avacta Group: Preliminary Results for the Year Ended 31 July 2016
Appendix
Methodology
About
Contact
Disclaimer

List of Tables
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Avacta Group Plc Pipeline Products by Equipment Type
Avacta Group Plc Pipeline Products by Indication
Avacta Group Plc, Key Facts
Avacta Group Plc, Major Products and Services
Avacta Group Plc Number of Pipeline Products by Development Stage
Avacta Group Plc Pipeline Products Summary by Development Stage
Depression Test - Product Status
Depression Test - Product Description
Diagnostic Assay - Alzheimer's Disease - Product Status
Diagnostic Assay - Alzheimer's Disease - Product Description
Diagnostic Test - ADHD - Product Status
Diagnostic Test - ADHD - Product Description
Diagnostic Test - Bipolar Disorder - Product Status
Diagnostic Test - Bipolar Disorder - Product Description
Point-Of-Care Diagnostic Test - Zika Virus - Product Status
Point-Of-Care Diagnostic Test - Zika Virus - Product Description
Portable Pathogen Detection System - Product Status
Portable Pathogen Detection System - Product Description
Rapid Diagnostic Test - Bacterial Strains - Product Status
Rapid Diagnostic Test - Bacterial Strains - Product Description
Rapid Diagnostic Test - Infectious Diseases - Product Status
Rapid Diagnostic Test - Infectious Diseases - Product Description
Schizophrenia Response Test - Product Status
Schizophrenia Response Test - Product Description
Schizophrenia Side Effects Test - Product Status
Schizophrenia Side Effects Test - Product Description
Avacta Group Plc, Key Employees
Avacta Group Plc, Other Locations
Avacta Group Plc, Subsidiaries
Glossary

List of Figures
Avacta Group Plc Pipeline Products by Equipment Type
Avacta Group Plc Pipeline Products by Development Stage 9
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Source BioScience (Healthcare) Ltd
  • Smith & Nephew Plc
  • Lidco Group Plc
  • Haemair Ltd
  • GlySure Ltd
  • Deltex Medical Group Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll